Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.

Researchers investigated how immune cells interact in people with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune condition that attacks the spinal cord and optic nerves. The study compared blood samples from NMOSD patients during active disease and remission periods with healthy individuals. Scientists found that during disease flare-ups, patients had significantly higher levels of specific immune cells called follicular helper T cells (Tfh) and certain B cells, which produce antibodies that mistakenly attack the body's own tissues. They also discovered elevated levels of inflammatory proteins including IL-6, IL-21, and CXCL13. Laboratory experiments showed these immune cells communicate with each other in ways that worsen the disease—Tfh cells encourage B cells to produce harmful antibodies, while B cells stimulate more Tfh cell activity, creating a damaging cycle. This research helps explain why NMOSD causes recurring attacks and why the immune system continues attacking healthy tissue. For patients considering complementary therapies like acupuncture, understanding these immune mechanisms is important because any treatment approach should ideally support rather than further activate an already overactive immune system. While this study didn't examine acupuncture specifically, the findings about inflammatory markers could help researchers design future studies to test whether acupuncture might help modulate these immune responses during remission periods, potentially reducing attack frequency. Always work with a licensed acupuncturist experienced in autoimmune conditions who can coordinate care with your neurologist.

This study examined circulating Tfh and B cell subsets in AQP4-ab-positive NMOSD patients during acute attacks and remission versus healthy controls using flow cytometry. During acute phases, patients demonstrated significantly elevated proportions of total Tfh cells, ICOS+ Tfh, activated Tfh17, switched memory B cells, double-negative B cells, plasmablasts, and plasma cells, with concurrent increases in serum IL-6, IL-21, and CXCL13. Conversely, activated Tfh1, naive B cells, and transitional regulatory B cell subsets were reduced. Functional co-culture assays revealed bidirectional pathogenic interactions: Tfh cells enhanced B cell proliferation, differentiation, and AQP4-ab production, while B cells promoted Tfh proliferation and IL-21 secretion—effects modulated by anti-CD20 and anti-IFN-γ antibodies but augmented by anti-IL-10 antibodies. Sample size and effect sizes were not specified. Clinical relevance: dysregulated Tfh/B cell crosstalk drives NMOSD pathogenesis, suggesting potential therapeutic targets for immune modulation during relapsing phases.